Dow Jones futures sold off 400 points Tuesday, as Moderna CEO Stephane Bancel predicted existing vaccines will be less effective for omicron. Read More...
Motley Fool
Is It Too Late to Buy Viatris Stock?
If you’re a fan of stable healthcare companies that have the potential to pay you ever-rising dividends until the cows come home, Viatris (NASDAQ: VTRS) might well become a dream stock. The single most persuasive argument against it being too late to buy Viatris is that the company is just getting started. After all, its life as an independent entity started a mere year ago with the merger of Pfizer’s generic drugs business, Upjohn, and Mylan.
